Grants Search Results

Need help? Call us at (888) 899-2253

Interested in applying for a St. Baldrick's Foundation grant? Learn more about the grant application process.

Showing 21-40 of 645 results

Funded: 07-01-2023 through 06-30-2025
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: The Children's Hospital of Philadelphia affiliated with University of Pennsylvania

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Project. For a description of this project, see the consortium grant made to the lead institution: University of California, Santa Cruz, Santa Cruz, CA.

Funded: 07-01-2023 through 06-30-2025
Funding Type: Consortium Research Grant
Institution Location: Ann Arbor, MI
Institution: University of Michigan affiliated with C.S. Mott Children’s Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Project. For a description of this project, see the consortium grant made to the lead institution: University of California, Santa Cruz, Santa Cruz, CA.

Funded: 07-01-2023 through 06-30-2025
Funding Type: Consortium Research Grant
Institution Location: San Francisco, CA
Institution: University of California, San Francisco affiliated with UCSF Benioff Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Project. For a description of this project, see the consortium grant made to the lead institution: University of California, Santa Cruz, Santa Cruz, CA.

Funded: 07-01-2023 through 06-30-2025
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: The Children's Hospital of Philadelphia affiliated with University of Pennsylvania

This institution is a member of a research consortium which is being funded by St. Baldrick's: Treehouse Childhood Cancer Project. For a description of this project, see the consortium grant made to the lead institution: University of California, Santa Cruz, Santa Cruz, CA.

Funded: 07-01-2023 through 06-30-2025
Funding Type: Consortium Research Grant
Institution Location: Santa Cruz, CA
Institution: University of California, Santa Cruz

Analyzing the genetic code of each patient's cancer enables researchers to identify specific errors that fuel the cancer in that patient. While the genetic code of patients in the clinics analyzed, it is currently difficult to analyze each patient in the context of all other patients. The Treehouse Consortium enables real-time sharing of pediatric cancer data generated by studies and clinical trials across the world, uniting data from diverse sources into a compendium of unprecedented scale. This group developed and made available to others methods to compare each child's cancer against over 12,000 childhood and adult tumors to improve treatment decisions. Fund administered by University of California, Santa Cruz.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Bronx, NY
Institution: Children's Hospital at Montefiore affiliated with Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Milwaukee, WI
Institution: Medical College of Wisconsin affiliated with Midwest Children's Cancer Center, Children's Hospital of Wisconsin

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Buffalo, NY
Institution: Roswell Park Cancer Institute affiliated with Women and Children's Hospital of Buffalo

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Minneapolis, MN
Institution: Children's Hospitals and Clinics of Minnesota affiliated with Children's - St. Paul

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: St. Louis, MO
Institution: Washington University in St. Louis affiliated with St. Louis Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: New York, NY
Institution: Columbia University Medical Center affiliated with Morgan Stanley Children’s Hospital, New York-Presbyterian

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: The Children's Hospital of Philadelphia affiliated with University of Pennsylvania

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Denver, CO
Institution: University of Colorado affiliated with Children's Hospital Colorado

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Atlanta, GA
Institution: Children's Healthcare of Atlanta affiliated with Emory University, Children's Healthcare of Atlanta at Egleston, Aflac Cancer Center

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: Comer Children's Hospital affiliated with The University of Chicago

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Seattle, WA
Institution: Seattle Children's Hospital affiliated with Fred Hutchinson Cancer Research Center, University of Washington

This institution is a member of a research consortium which is being funded by St. Baldrick's: Precision–based Therapy for Childhood Leukemia. For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Philadelphia, PA
Institution: Children's Oncology Group

This institution is a member of a research consortium which is being funded by St. Baldrick's: Malignant Germ Cell Tumors International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: San Diego, CA
Institution: University of California, San Diego affiliated with Rady Children's Hospital San Diego

This institution is a member of a research consortium which is being funded by St. Baldrick's: Malignant Germ Cell Tumors International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: San Diego, CA
Institution: University of California, San Diego affiliated with Rady Children's Hospital San Diego

This institution is a member of a research consortium which is being funded by St. Baldrick's: Malignant Germ Cell Tumors International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana–Farber Cancer Institute, Boston, MA.

Funded: 07-01-2023 through 06-30-2024
Funding Type: Consortium Research Grant
Institution Location: Los Angeles, CA
Institution: Children's Hospital Los Angeles

High-Risk neuroblastoma (HR-NB) is an aggressive pediatric cancer, with only half of patients surviving. New Approaches to Neuroblastoma Therapy (NANT) headquartered at Children’s Hospital Los Angeles is the only group focused on new treatments based on lab data for HR-NB. NANT includes a team of 18 children’s hospitals across nationally and internationally working together to design new treatments, treat patients, and use what is learned to design the next treatments. New treatments include helping patients’ own immune system kill tumor by increasing and activating immune cells. Another treatment uses radiation therapy focused on the tumor combined with medicines to help the immune system recognize tumor. Trials include special tests on patients’ blood and bone marrow to understand how treatments work, find tiny amounts of tumor and new therapy targets. NANT trials help kids with aggressive NB that has come back. Funds administered by Children's Hospital Los Angeles. This grant is named for the LukeStrong a Force Against Neuroblastoma Childhood Cancer Fund. When Luke was 5 years old, he was diagnosed with high-risk neuroblastoma. He is now in his teens and still in active treatment for relapsed neuroblastoma. Since 2014 Luke’s “Never tell me the odds” attitude has inspired his family and friends to shave their heads, fundraise with St. Baldrick’s, and help conquer childhood cancers.